McCarthy Teresa bought RNA
August 15, 2025 · Form 4 insider transaction
McCarthy Teresa bought 10,000 shares of Atrium Therapeutics, Inc. at $22.34 per share, a transaction worth $223.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$22.34
Total value
$223.4K
InsiderMcCarthy Teresa
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 15, 2025
Filing dateAugust 15, 2025
Shares owned after107,130
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on April 11, 2025.